--- title: "12 Health Care Stocks Moving In Friday's Intraday Session" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/275930262.md" description: "In Friday's trading session, several health care stocks experienced significant movements. American Well (AMWL) surged 31.2% to $5.68, while Phio Pharma (PHIO) rose 28.68% to $1.57. Other gainers included Immunic (IMUX) up 27.57%, Cypherpunk Technologies (CYPH) up 21.12%, and Oncolytics Biotech (ONCY) up 18.59%. Conversely, Intensity Therapeutics (INTS) fell 26.3% to $0.27, Geovax Labs (GOVX) dropped 23.85% to $1.76, and Upstream Bio (UPB) decreased 21.22% to $10.09. Overall, the market showed volatility among health care stocks following Q4 earnings announcements." datetime: "2026-02-13T17:05:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275930262.md) - [en](https://longbridge.com/en/news/275930262.md) - [zh-HK](https://longbridge.com/zh-HK/news/275930262.md) --- > 支持的语言: [English](https://longbridge.com/en/news/275930262.md) | [繁體中文](https://longbridge.com/zh-HK/news/275930262.md) # 12 Health Care Stocks Moving In Friday's Intraday Session ### Gainers - **American Well** (NYSE:AMWL) stock moved upwards by 31.2% to $5.68 during Friday's regular session. The market value of their outstanding shares is at $68.4 million. The company's, Q4 earnings came out yesterday. - **Phio Pharma** (NASDAQ:PHIO) stock increased by 28.68% to $1.57. The market value of their outstanding shares is at $13.1 million. - **Immunic** (NASDAQ:IMUX) shares rose 27.57% to $1.11. The company's market cap stands at $104.6 million. - **Cypherpunk Technologies** (NASDAQ:CYPH) stock rose 21.12% to $0.73. The company's market cap stands at $33.9 million. - **Oncolytics Biotech** (NASDAQ:ONCY) shares increased by 18.59% to $0.99. The market value of their outstanding shares is at $89.8 million. - **CASI Pharmaceuticals** (NASDAQ:CASI) shares rose 17.59% to $0.88. The market value of their outstanding shares is at $11.5 million. ### Losers - **Intensity Therapeutics** (NASDAQ:INTS) shares fell 26.3% to $0.27 during Friday's regular session. The market value of their outstanding shares is at $22.2 million. - **Geovax Labs** (NASDAQ:GOVX) shares fell 23.85% to $1.76. The market value of their outstanding shares is at $4.0 million. - **Upstream Bio** (NASDAQ:UPB) shares fell 21.22% to $10.09. The market value of their outstanding shares is at $691.6 million. - **OKYO Pharma** (NASDAQ:OKYO) stock decreased by 20.51% to $1.73. The market value of their outstanding shares is at $88.0 million. - **Sensus Healthcare** (NASDAQ:SRTS) stock decreased by 18.18% to $3.81. The market value of their outstanding shares is at $76.3 million. As per the press release, Q4 earnings came out yesterday. - **Polaryx Therapeutics** (NASDAQ:PLYX) stock decreased by 16.1% to $2.45. The company's market cap stands at $138.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### 相关股票 - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-CN/quote/IBBQ.US.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-CN/quote/XLV.US.md) - [Intensity Therapeutics (INTS.US)](https://longbridge.com/zh-CN/quote/INTS.US.md) - [Upstream Bio (UPB.US)](https://longbridge.com/zh-CN/quote/UPB.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md) - [Phio Pharmaceuticals (PHIO.US)](https://longbridge.com/zh-CN/quote/PHIO.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md) - [GeoVax Labs (GOVX.US)](https://longbridge.com/zh-CN/quote/GOVX.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md) - [Immunic (IMUX.US)](https://longbridge.com/zh-CN/quote/IMUX.US.md) - [iShares US Healthcare Providers (IHF.US)](https://longbridge.com/zh-CN/quote/IHF.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-CN/quote/ARKG.US.md) - [American Well (AMWL.US)](https://longbridge.com/zh-CN/quote/AMWL.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [SPDR S&P Health (XHS.US)](https://longbridge.com/zh-CN/quote/XHS.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md) - [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-CN/quote/IXJ.US.md) - [Oncolytics Biotech (ONCY.US)](https://longbridge.com/zh-CN/quote/ONCY.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md) - [Cypherpunk Tech (CYPH.US)](https://longbridge.com/zh-CN/quote/CYPH.US.md) ## 相关资讯与研究 - [Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany](https://longbridge.com/zh-CN/news/279232104.md) - [HealthTrust Advances the Future of Clinically Aligned Performance at 2026 FAH Conference](https://longbridge.com/zh-CN/news/278743138.md) - [Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/zh-CN/news/279226861.md) - [Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis | ACRS Stock News](https://longbridge.com/zh-CN/news/279581540.md) - [Pfizer announces positive topline phase 2 results for next-generation CDK4 inhibitor, atirmociclib, in second-line metastatic breast cancer](https://longbridge.com/zh-CN/news/279429425.md)